Morgan Stanley Maintains Overweight on Agree Realty, Raises Price Target to $77
Morgan Stanley analyst Ronald Kamdem maintains Agree Realty (NYSE:ADC) with a Overweight and raises the price target from $75 to $77.
Raymond James Maintains Strong Buy on Agree Realty, Raises Price Target to $85
Raymond James analyst RJ Milligan maintains Agree Realty (NYSE:ADC) with a Strong Buy and raises the price target from $76 to $85.
Analyst Ratings for Agree Realty
Over the past 3 months, 4 analysts have published their opinion on Agree Realty (NYSE:ADC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Benzinga Pro’s Top 5 Stocks To Watch For Thursday, Jun. 2, 2022: CHWY, MAT, LULU, ADC, CTO
Today's 5 Stock Ideas:
Chewy (CHWY) - Shares were up nearly 20% Thursday morning following better-than-expected Q1 sales. The stock was a top-trending mention on Reddit's WallStreetBets.
Mattel (MAT)
B of A Securities Upgrades Agree Realty to Buy, Raises Price Target to $78
B of A Securities analyst Joshua Dennerlein upgrades Agree Realty (NYSE:ADC) from Neutral to Buy and raises the price target from $76 to $78.
Agree Realty Priced 5M Share Offering @$68.65/Share
Agree Realty Corporation (NYSE: ADC) (the "Company") today announced the pricing of its public offering of 5,000,000 shares of its common stock at a public offering price of $68.65 per share in connection with the forward sale agreements described below.
Where Agree Realty Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Agree Realty (NYSE:ADC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Earnings Scheduled For May 3, 2022
Companies Reporting Before The Bell
• Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.